BVI Medical

BVI Medical BVI® is refocusing the future of vision. We trust and empower our associates to make decisions and solve problems because collaboration drives us.

As one of the fastest-growing, diversified surgical ophthalmic businesses in the world, our purpose-built portfolio of trusted brands includes: Beaver® (Knives and Blades), Visitec® (Cannulas), Malosa® (Single-Use Instruments), Vitreq® (Vitreoretinal Surgical Products) and PhysIOL® (Premium IOLs), and spans more than 90 countries. We’ve set our sights on touching the lives of millions of patients affected by conditions such as cataracts, refractive error, glaucoma, retinal disease, and dry eye. Unburdened by legacy or bureaucracy, we have developed our strategy around a simple concept – taking pride in delivering innovative solutions for our physicians and patients, based on their needs. Valuing agility, simplicity, and transparency, we stay committed to listening to our customers, delivering for our patients, and keeping the future in focus.

11/27/2025

“When you put the IOL in the eye, it’s very easy to rotate the IOL to the right or to the left.”
Having first used the platform two years ago with the PODEYE monofocal lens, Dr Romain Mouchel explains that with , he has experienced both intra-operative maneuverability and post-operative stability — in this short episode of POD PLATFORM IN FOCUS.
To learn more about the POD platform, take a look at our brochure: https://loom.ly/1iUWYa0
Not all products or offerings are approved or available in every market.

Come and join us at the Floretina Congress as we unveil market-leading applications for vitreoretinal and cataract surge...
11/25/2025

Come and join us at the Floretina Congress as we unveil market-leading applications for vitreoretinal and cataract surgery with our new Virtuoso® phaco-vitrectomy platform.
Learn more about our initiatives at Floretina 2025 https://www.bvimedical.com/floretina-2025/

11/20/2025

In addition to the stability and maneuverability of the platform, Dr David Shahnazaryan (UK) shares how he decides which patients are candidates for the Trifocal IOL and which are better suited to the Premium Monofocal IOL in today’s “POD Platform in Focus” video.
Dr Shahnazaryan also discusses lens selection, patient suitability, and achieving predictable outcomes in cataract and presbyopia correction.

Not all products or offerings are approved or available in every market.

Last week, our community came together to celebrate World Quality Day and reaffirm our commitment to delivering high-q...
11/20/2025

Last week, our community came together to celebrate World Quality Day and reaffirm our commitment to delivering high-quality ophthalmic and surgical products that exceed customer and regulatory expectations. 🙌

From fitness challenges to a custom Escape Room, teams put our BVI values—integrity, accountability, and collaboration—into action, testing their agility and strengthening connection across the organization. 💡

We’re thrilled to sponsor an exclusive learning experience at Floretina! An exciting opportunity to explore the clinical...
11/19/2025

We’re thrilled to sponsor an exclusive learning experience at Floretina! An exciting opportunity to explore the clinical potential of endoscopy and Endoscopic Cyclophotocoagulation (ECP) in VR surgery, led by two esteemed surgeons, Dr. Sébastien Guigou and Dr. Loïc Bazin.
We look forward to seeing you there!
Learn more about our activities at Floretina Congress https://www.bvimedical.com/floretina-2025/

11/17/2025

We can’t stop talking about BVI’s presence at — what an incredible year! 🙌

From launching Leos™ to celebrating the FDA approval of FINEVISION HP, our teams reflect what sets us apart: Authenticity, collaboration, pride and a genuine commitment to advancing vision care.

Join us at the Floretina Congress and explore the full potential of BVI’s innovative portfolio for vitreoretinal surgery...
11/14/2025

Join us at the Floretina Congress and explore the full potential of BVI’s innovative portfolio for vitreoretinal surgery. Visit us at booth #29 to discover how our latest solutions are advancing surgical outcomes and supporting ophthalmic professionals worldwide.
Learn more about our initiatives at https://www.bvimedical.com/floretina-2025/

Today, we celebrate our , the vigilance and teamwork that enable us to meet surgeons' needs and protect their patients....
11/13/2025

Today, we celebrate our , the vigilance and teamwork that enable us to meet surgeons' needs and protect their patients.

Together, we can protect sight and change lives.

With a novel, one-of-a-kind open double C-loop haptic design, the POD platform certainly ticks the ‘innovation’ box when...
11/12/2025

With a novel, one-of-a-kind open double C-loop haptic design, the POD platform certainly ticks the ‘innovation’ box when it comes to ‘having it all’ — but how does it fare when it comes to clinical performance?
Swipe to see the consistent refractive performance for:
• Far
• Intermediate
• Near vision
Available with all BVI optic technologies — take a look at the POD platform brochure: https://loom.ly/LQMX1fU
Not all products or offerings are approved or available in every market.

Conclusion: “Patients implanted with the new Isopure Serenity IOL with double C-loop haptics showed good visual performa...
11/07/2025

Conclusion: “Patients implanted with the new Isopure Serenity IOL with double C-loop haptics showed good visual performance at far distance with functional intermediate vision and accurate refractive outcomes.”
👉 Are you curious to see 3-month follow-up data for the ISOPURE SERENITY premium monofocal IOL? This latest peer-reviewed, multicenter study reports outcomes across a range of key parameters, including refraction, visual acuity at far, intermediate (80 cm & 66 cm), and near (40 cm) distances, as well as the binocular defocus curve.

Congratulations to Mr Sheraz Daya, Dr Takayuki Akahoshi, Dr Camille Bosc, Dr Christophe Chassain, Dr Romain Mouchel, Dr Emmanuel Van Acker, Dr Alessandra Di Maria, and Dr Paolo Fogagnolo on the recent publication of their paper: “Clinical Outcomes of a Multicenter Study Following Implantation of an Isofocal Optic IOL with Double C-Loop Haptics.”
Launched at the 2024 ESCRS, ISOPURE SERENITY® & SERENITY TORIC® premium monofocal IOLs feature patented, non-diffractive ISOFOCAL optic technology and our groundbreaking double C-loop POD platform — specifically designed for the improved stability required by toric IOLs for long-term, accurate astigmatism correction.

Not all products or offerings are approved or available in every market.

In addition to post-operative rotational stability, the double C-loop platform can be rotated clockwise or countercloc...
11/05/2025

In addition to post-operative rotational stability, the double C-loop platform can be rotated clockwise or counterclockwise1 to align the toric IOL with the intended axis - a benefit made possible by its symmetrical design.
The POD platform is available with all BVI optic technologies. Speak to your local BVI representative today to learn why surgeons trust it.
Not all products or offerings are approved or available in every market.
https://www.bvimedical.com/contact-us/

11/04/2025

Why BVI? Hear it straight from our people!

Whether it’s our shared mission, culture, or the impact we aim to make with our work, our community has powerful desires to join—and stay at—BVI.

👉 Ready to join us? Explore opportunities here: https://www.bvimedical.com/careers

Address

303 Wyman Street
Waltham, MA
MA02451

Telephone

+18669068080

Website

Alerts

Be the first to know and let us send you an email when BVI Medical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

Specialized in the research, development and manufacture of innovative optical solutions for cataract surgery, our products are supplied to ophthalmic surgeons in over 70 countries, through a worldwide network. Our expertise covers all steps of development and manufacture of intraocular lenses. It extends from polymer chemistry through to sterilization processes, including modelling and risk-control associated with implantable materials.